RW, continuation of IMMU/BIOM ramble ...
Here is a portion of the "shrine" dealing with anti-CD22:
geocities.com
Has not been updated in a while. They most definitely have a viable project here, or projects labeled and naked. But, this is going to take a while as they are early in phase II, to my knowledge.
Also, I have not looked at the CEA project. If any good, this can be much larger than anti-CD22 given the potential indications. Think IMCL. Any data you are aware of?
I hate IMMU primarily because I saw it at 1 and change not long ago, even at 4 or so, thought it was a give away, and yet never got a single share. As consolation, still holding some ARIA from the 1 and change days. Talk about momo; if they ever back it up with some partnerships it could get very scary.
I did write CLL not CLTR; seems the worst you can do these days is being too close to dealing with the FDA, better to stay with dreams and prayers. Nibbling on PPDI, my "cryptogenomics" play as well as OK CRO, though Rick H. via a colleague came up with a much better one so far, NBSC.
Oops, realize most of this is well over 10, let alone 1. Oh well.
PB |
